Hancock Jaffe Changes Name To enVVeno, Drops Cardiac Device To Focus On Venous Disease
The company will focus on developing its VenoValve system to treat chronic venous insufficiency and a second product for venous disease.
The company will focus on developing its VenoValve system to treat chronic venous insufficiency and a second product for venous disease.